Healthcare

Bain Capital and Bristol Myers Squibb form new biopharma company

The newly formed company launches with a $300 million financing commitment led by Bain Capital.

28 July 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.